167 related articles for article (PubMed ID: 2985300)
61. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.
Tabarin A; Laurent F; Catargi B; Olivier-Puel F; Lescene R; Berge J; Galli FS; Drouillard J; Roger P; Guerin J
Clin Endocrinol (Oxf); 1998 Sep; 49(3):293-300. PubMed ID: 9861318
[TBL] [Abstract][Full Text] [Related]
62. Pituitary pro-opiomelanocortin-cell carcinoma occurring in conjunction with a glioblastoma in a patient with Cushing's disease and subsequent Nelson's syndrome.
Gabrilove JL; Anderson PJ; Halmi NS
Clin Endocrinol (Oxf); 1986 Aug; 25(2):117-26. PubMed ID: 3024876
[TBL] [Abstract][Full Text] [Related]
63. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
[TBL] [Abstract][Full Text] [Related]
64. Hypergastrinaemia in Cushing's syndrome: pituitary origin or glucocorticoid-induced?
López-Guzmán A; Salvador J; Frutos R; Díez JJ; Iglesias P; Sastre J; G-omez-Pan A
Clin Endocrinol (Oxf); 1996 Mar; 44(3):335-9. PubMed ID: 8729533
[TBL] [Abstract][Full Text] [Related]
65. Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing's syndrome: a study of 210 cases.
Kuhn JM; Proeschel MF; Seurin DJ; Bertagna XY; Luton JP; Girard FL
Am J Med; 1989 Jun; 86(6 Pt 1):678-84. PubMed ID: 2543219
[TBL] [Abstract][Full Text] [Related]
66. The development of Cushing's syndrome from a previously silent pituitary tumour.
Cooper ME; Murray RM; Kalnins R; Woodward J; Jerums G
Aust N Z J Med; 1987 Apr; 17(2):249-51. PubMed ID: 3039955
[TBL] [Abstract][Full Text] [Related]
67. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin.
Suda T; Abe Y; Demura H; Demura R; Shizume K; Tamahashi N; Sasano N
J Clin Endocrinol Metab; 1979 Sep; 49(3):475-7. PubMed ID: 224076
[TBL] [Abstract][Full Text] [Related]
68. Recurrent Cushing's disease: successful treatment by pituitary irradiation or trans-sphenoidal hypophysectomy in two cases.
Caplan RH; Annis BL
Neurosurgery; 1980 Aug; 7(2):160-5. PubMed ID: 6252506
[TBL] [Abstract][Full Text] [Related]
69. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
[TBL] [Abstract][Full Text] [Related]
70. [Evaluation of the accuracy of inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
Tóth M; Vajda Z; Görömbey Z; Molnár F; Major L; Toke J; Szabolcs I; Szücs N; Kovács L; Kiss R; Czirják S; Füto L; Gláz E; Góth M; Rácz K
Orv Hetil; 2007 May; 148(18):843-7. PubMed ID: 17468067
[TBL] [Abstract][Full Text] [Related]
71. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
72. PRKAR1A-negative familial Cushing's syndrome: two case reports.
Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
[TBL] [Abstract][Full Text] [Related]
73. Cushing's disease and craniopharyngioma.
Ackland FM; Stanhope R; Preece MA
Arch Dis Child; 1987 Oct; 62(10):1077-8. PubMed ID: 2823728
[TBL] [Abstract][Full Text] [Related]
74. [The treatment of Cushing's syndrome by selective excision of pituitary adenoma. 3 cases (author's transl)].
Riviere J; Manciet G; Roger P; Guerin J; Barraud AM; Mauriac L; Kern AM; Rashedi M
Nouv Presse Med; 1979 Jun; 8(27):2255-9. PubMed ID: 226930
[TBL] [Abstract][Full Text] [Related]
75. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.
Reimondo G; Paccotti P; Minetto M; Termine A; Stura G; Bergui M; Angeli A; Terzolo M
Clin Endocrinol (Oxf); 2003 Jun; 58(6):718-24. PubMed ID: 12780748
[TBL] [Abstract][Full Text] [Related]
76. Cushing's disease arising from a clinically nonfunctioning pituitary adenoma.
Salgado LR; Machado MC; Cukiert A; Liberman B; Kanamura CT; Alves VA
Endocr Pathol; 2006; 17(2):191-9. PubMed ID: 17159252
[TBL] [Abstract][Full Text] [Related]
77. Silent pituitary apoplexy: subclinical infarction of an adrenocorticotropin-producing pituitary adenoma.
Findling JW; Tyrrell JB; Aron DC; Fitzgerald PA; Wilson CB; Forsham PH
J Clin Endocrinol Metab; 1981 Jan; 52(1):95-7. PubMed ID: 6256408
[TBL] [Abstract][Full Text] [Related]
78. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
[TBL] [Abstract][Full Text] [Related]
79. An immunoperoxidase study of a human pituitary adenoma associated with Cushing's syndrome.
Wowra B; Peiffer J
Pathol Res Pract; 1984 Mar; 178(4):349-54. PubMed ID: 6328462
[TBL] [Abstract][Full Text] [Related]
80. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
